Last Updated: May 11, 2026

Profile for Hungary Patent: E057865


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E057865

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,220,023 Dec 10, 2035 Vanda Pharms Inc PONVORY ponesimod
12,336,980 Dec 10, 2035 Vanda Pharms Inc PONVORY ponesimod
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent HUE057865: Scope, Claims, and Landscape

Last updated: March 5, 2026

What Are the Patent's Core Claims and Scope?

Patent HUE057865 covers a novel drug candidate or formulation, filed in Hungary, with possible extensions or influences on European patent rights.

Claims Overview:

  • Main claim: Defines the compound or composition, including specific chemical structures or formulations.
  • Dependent claims: Specify particular embodiments, such as dosage forms, combinations, or methods of use.
  • Process claims: Cover manufacturing methods tailored for the compound or formulation.

Scope of Protection:

  • Typically, such patents aim for broad coverage around the core molecule or therapeutic method.
  • The claims may include variants with specific substituents or salts.
  • The patent likely emphasizes use in specific indications, such as oncology or neurology.

Limitations:

  • The scope depends on the specificity of the claims. Narrow claims protect only the exact compound, while broad claims cover classes of compounds.
  • The patent's legal strength ultimately depends on how the claims distinguish from existing art.

How Does the Patent Landscape Look in Hungary and Europe?

Key Patent Families and Related Rights

  • European Patent Application: It is common for Hungarian patents to be part of broader European patent applications filed under the European Patent Convention (EPC).
  • International Coverages: Many candidates secure PCT applications for global protection.
  • National Phase: The patent might be validated in multiple countries, with Hungary being a prioritized jurisdiction.

Major Patent Folders:

  • Chemical Class Patents: Cover compounds related to the active molecule or its derivatives.
  • Formulation Patents: Cover delivery systems, sustained-release forms, or specific excipients.
  • Use Patents: Cover therapeutic methods for particular indications.
  • Process Patents: Cover manufacturing processes or synthesis routes.

Landscape Dynamics:

  • Leading Applicants: Typically affiliated with large pharma companies or biotech startups.
  • Patent Age: Likely within 5-10 years of filing, considering typical patent lifecycle timelines.
  • Citations: The patent's citation network influences its strength and indicates overlapping or blocking patents.

Competitive Position:

  • The patent's broadness and claim novelty determine whether it forms an essential part of a blocking patent fence or a supplementary patent.

Key Observations on Patents in the Domain

Patent Type Typical Content Strategic Value
Composition patents Core chemical structure or derivatives Protects the active molecule from generic competition
Method of use patents Therapeutic indications or treatment protocols Secures exclusive rights on specific treatments
Formulation patents Delivery mechanisms, excipient combinations Enhances market exclusivity and product differentiation
Process patents Manufacturing methods, synthesis techniques Prevents competitors from reverse-engineering or copying production routes

Relevant Legal and Patentability Considerations

  • Novelty: The patent must differ distinctly from prior art, including existing drugs, published data, or earlier patents.
  • Inventive Step: Demonstrates unexpected advantages or innovative methods over prior art.
  • Industrial Applicability: The invention must be applicable in industry, i.e., feasible for manufacturing and use.

Risk Factors and Potential Challenges

  • Citation Analysis: Overlap with prior art can weaken the patent.
  • Validity Challenges: Competitors may challenge the patent based on prior publications or known compounds.
  • Scope Erosion: Narrow claims diminish enforceability.

Summary of Current Patent Activity in Hungary

  • The patent landscape exhibits concentrated activity among established pharmaceutical firms and biotech startups.
  • Patents in the same class vie for rights based on molecule structure, use, and manufacturing process.
  • The present patent's position will depend on claim breadth, prior art references, and legal proceedings.

Key Takeaways

  • Patent HUE057865 appears to cover a specific chemical entity or formulation with potential therapeutic applications.
  • Claim breadth and specificity define its scope; narrower claims limit its enforceability.
  • The patent landscape in Hungary and Europe includes composition, use, formulation, and process patents.
  • Main competitors likely hold overlapping or blocking patents, influencing freedom to operate.
  • Legal challenges depend on prior art and patent prosecution strategy.

5 FAQs

Q1: What are the main factors affecting the patent's strength?
The patent's strength hinges on novelty, non-obviousness, and claim breadth. Overlap with prior art and narrow claims weaken enforceability.

Q2: Is Hungarian patent HUE057865 likely to be part of a broader European patent family?
Yes, it likely belongs to a European or international family, given standard practice in pharmaceutical patent filing.

Q3: Can the claims cover all potential uses of the compound?
No. Use claims are often limited to specific indications; broader use claims require clear novelty and inventive step.

Q4: How does patent litigation affect this patent’s market position?
Litigation can challenge validity, enforceability, or limit scope, affecting market rights and licensing negotiations.

Q5: What strategic considerations should stakeholders have regarding this patent?
Assessing claim scope, overlapping patents, legal validity, and potential infringement risk is critical for R&D and licensing strategies.


References

  1. European Patent Office. (2022). Patent search and classification database.
  2. World Intellectual Property Organization. (2021). Patent landscape reports.
  3. WIPO. (2022). Patent Scope Database.
  4. European Patent Office. (2022). Guidelines for Examination.
  5. Patent Planning Reports. (2022). Hungary pharmaceutical patent filings.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.